Marianne Hauglid Flågeng
Publications
Academic articles
2018
A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells
Journal of Steroid Biochemistry and Molecular Biology
185
p. 57-70
2016
Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers
Journal of Steroid Biochemistry and Molecular Biology
165
p. 228-235
2015
The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells
PLOS ONE
10
2015
Estrogens correlate with PELP1 expression in ER positive breast cancer
PLOS ONE
10:e0134351
2014
Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells
Biochemical and Biophysical Research Communications - BBRC
450
p. 360-365
2013
Downregulation of steroid receptor coactivator-2 modulates estrogen-responsive genes and stimulates proliferation of MCF-7 breast cancer cells
PLOS ONE
8
2013
Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue
PLOS ONE
8
2012
Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer
BMC Cancer
12
2010
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue
Clinical Cancer Research
16
p. 2176-2186
2010
cAMP-mediated regulation of HNF-4 alpha depends on the level of coactivator PGC-1 alpha
BBA - Molecular Cell Research
1803
p. 1013-1019
2009
Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors
British Journal of Cancer
101
p. 1253-1260
2008
Recruitment of coactivator glucocorticoid receptor interacting protein 1 to an estrogen receptor transcription complex is regulated by the 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase
Endocrinology
149
p. 4336-4345
2008
Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism
Annals of Oncology
19
p. 56-61
2005
Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry
Journal of Chromatography A
1082
p. 6-14
Other journal contributions
2008
A study of associations between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferase 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady state tamoxifen treatment
Breast Cancer Research and Treatment
109
p. 592-592
2007
Effect of CYP2D6 and SULT1A1 genotypes on the serum concentration of 4-hydroxytamoxifen and 4-hydroxy-N-demethyltamoxifen during steady state treatment of breast cancer patients
Breast
16
p. S15-S15
2007
A study of associations between estrogen and tamoxifen metabolism, cytochrome 2D6 and sulfotransferase 1A1 polymorphisms, and sulfotransferase 1A1 gene copy number during steady state tamoxifen treatment
Breast Cancer Research and Treatment
S106
2005
Relationship between CYP2D6 and SULT1A1 genotypes and serum concentrations of tamoxifen and its metabolites during steady state treatment in breast cancer patients
Breast Cancer Research and Treatment
94
p. S236-S237
Scientific lectures
2023
Pesticides in novel plant-based salmon feeds and farmed Atlantic salmon
NPRW 2023
2019
Identification of pesticide metabolites in farmed fish by use of LC coupled to ion mobility and HRMS
Poster
2014
Steroid receptor coactivators during short-term estrogen deprivation
2012
Inverse regulation of Neuregulin 1 and HER-3 during treatment with aromatase inhibitors of estrogen receptor-positive breast cancer
2011
The nuclear receptor coactivator PELP1/MNAR is positively correlated with estrogen levels in breast cancer patients
2011
Characterization of Global Gene Expression in Breast Cancer Cells after cAMP/PKA-mediated downregulation of Steroid Receptor Coactivator 2
2010
The influence of tamoxifen treatment on the expression levels of liver receptor homolog (LHR-1)
2010
Expression of Steroid Receptor Coactivators and HER-2/neu in normal and malignant breast tissue in controls and tamoxifen treated patients
2010
Epidermal growth factor receptors (ErbB/HER) and the ligand Neuregulin 1 (NRG1) increase in breast tumors during short time treatment with aromatase inhibitors
2009
PTH inhibits ligand-dependent activation of estrogen receptor alfa in MC3T3 osteoblasts
2009
HER-2/neu and nuclear receptor coactivators are upregulated in breast cancer tumors during estrogen deprivation
2009
PTH inhibits ligand-dependent activation of estrogen receptor alfa in MC3T3 Osteoblasts
2009
Role of the cAMP-PKA Signaling Pathway in the Regulation of ERalpha-dependent transcription by Steroid Receptor Coactivators in Breast Cancer Cells
2008
Changes in mRNA expression levels of steroid receptor coactivators correlate with treatment response to aromatase inhibition in human breast cancer
2007
Effect of CYP2D6 and SULT1A1 Genotypes on the serum concentration of 4-OHtamoxifen and 4-OH-N-Demethyltamoxifen during steady state treatment of breast cancer patients
2005
Relationship between CYP2D6 and SULT1A1 genotypes and serum concentrations of tamoxifen and its metabolites during steady state treatment in breast cancer patients
Reports and dissertations
2011
Steroid receptor coactivators and epidermal growth factor receptors in breast cancer
2010
Endring i genekspresjon under endokrin behandling av brystkreft
Is this your profile? Edit your profile (login)